We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

U.S. markets close in 5 hours 27 minutes

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real Time Price. Currency in USD
48.85-0.05 (-0.10%)
As of 10:33AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Descending Continuation Triangle

Descending Continuation Triangle

Previous Close48.90
Bid48.76 x 1100
Ask48.77 x 1000
Day's Range48.57 - 48.98
52 Week Range48.42 - 81.44
Avg. Volume12,392,951
Market Cap99.398B
Beta (5Y Monthly)0.37
PE Ratio (TTM)12.40
EPS (TTM)3.94
Earnings DateFeb 02, 2024
Forward Dividend & Yield2.28 (4.66%)
Ex-Dividend DateOct 05, 2023
1y Target Est63.23
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for BMY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Bristol-Myers Squibb Company
    Analyst Report: Bristol-Myers Squibb Co.Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, immunology and cardiovascular conditions. The company completed its merger with Celgene in November 2019. BMY shares are a component of the S&P 500.
    Fair Value
    Economic Moat
    21 days agoArgus Research
View more